REFERENCE FORMULA
Reference formula
Reference basis: 100 g finished cream;2% w/w
| Ingredient | Source quantity | Scaled quantity |
|---|---|---|
| Erythromycin | 2 g | — |
| Ethanol 96% | q.s. βλ. διαδικασία / see method | — |
| Nonionic O/W emulsion 1, EX010 | q.s. ad 100 g | — |
Prerequisite formulations
Documentation
Preparation description
White, firm cream containing 20 mg erythromycin per g. This specific nonionic O/W emulsion is not interchangeable with any commercial erythromycin gel. [1]
Action and use
Specifications
White firm homogeneous cream without phase separation or visible crystals; final mass 100 g. FN supplies no numeric finished pH, viscosity or assay limits. [1]
Light
Protect in opaque packaging. Storage data for a commercial alcoholic gel are not transferred to this cream. [1]
Air and oxidation
Water and solubility
Humidity
Temperature
pH and compatibility
Other interactions
Ingredient-specific information
Staff protection
Risk assessment
Compounding conditions
BUD rationale
AEMPS states 3 months below 30 °C, protected from light. This sheet chooses a conservative 35-day ceiling at 20–25 °C under the general preserved-aqueous framework, not demonstrated stability. Base must retain the exact EX001 preservative system. No independent study of this cream, aw or final-product AET was retrieved; antibiotic activity does not substitute for them. Earlier base/ingredient dating controls. Editorial convention: calendar-month source periods are retained as calendar periods; the calendar-period conversion ceiling is 28 days for one month or 89 days for three months; a separately selected shorter ceiling still governs. It is a conservative conversion, not a source quotation. [1], [2], [6], [7]
Prerequisites
EX010→CGR-ES-019; its preserved water EX001→CGR-ES-018. The nonionic self-emulsifier must match the qualified base, not any generic cream vehicle. [1], [2], [7]
Equipment
Compounding method
Prepare EX010 by its defined base procedure. Dissolve 2 g erythromycin in a small measured quantity of ethanol 96%. At the final stage gradually incorporate into the cream with gentle mixing, then make up to 100 g using the same base. Homogenise without aeration and inspect for separation/crystals before filling. [1], [2]
Observations
Container and packaging
Use compatible opaque packaging with effective closure. Tube or narrow-opening pack may reduce handling contamination after compatibility qualification; source itself specifies an opaque container. [1]
Quality control
Storage
Dispensing
Labelling
v9_controls
The numeric value is a literature reference ceiling subject to its specific conditions. No actual batch BUD has been assigned and no aw measurements have been produced. The exact formula, prerequisites, container, storage and quality evidence require approval for the actual application. The BUD clock starts when compounding begins. Use the shortest applicable supported limit and assess in-use dating separately. USP categories are a technical framework and are not presented as Greek legislation.
Sources and references
- AEMPS — Formulario Nacional — FN/2003/FMT/007 ERITROMICINA, CREMA DECurrent AEMPS standalone PDF; code FN/2003/FMT/007PDF p 2 §§3–7; subsequent safety and patient informationExact formulation, process, source shelf life and formulation-specific precautions; independent factual compilation, not official translation.2026-10-14
- AEMPS — Formulario Nacional — FN/2003/EX/010 EMULSIÓN O/A NO IÓNICA 1Current AEMPS standalone PDF; code FN/2003/EX/010PDF p 2 §§3–7; subsequent safety and patient informationExact formulation, process, source shelf life and formulation-specific precautions; independent factual compilation, not official translation.2026-10-13
- NICE NG 198 — Acne vulgaris: managementCurrent recommendation retrieved 13 October 2026Recommendation 1.5.11; rationale on antibiotic monotherapyOfficial clinical guideline: avoid antibiotic monotherapy for acne; no formulation or stability claim. Indexed official recommendation and rationale retrieved; direct page access intermittently 403.2026-10-13
- DailyMed — ERYGEL erythromycin topical gel 2% labelLabel revisedJune 2018; listing marketing end 30 September 2025; retrieved 13 October 2026Description, contraindications, warnings, precautionsPrimary archived product label supporting erythromycin identity/solubility and topical safety, not evidence of current marketing or this cream BUD.2026-10-13
- CDC/NIOSH Pocket Guide — Ethyl alcoholPage reviewed 30 October 2019; retrieved 13 October 2026Flammability, incompatibilities and personal protectionEthanol raw-material handling; not a measured flash point or hazard classification of the finished mixture.2026-10-13
- USP — Compounding Standards and Beyond-Use DatesNovember 2022 USP publication, public copy hosted by Mississippi Boardp 2 nonsterile comparison tableGeneral category limits only; not product-specific stability, antimicrobial effectiveness or Greek law.2026-10-13
- AEMPS — Formulario Nacional — FN/2003/EX/001 AGUA CONSERVANTECurrent AEMPS standalone PDF; code FN/2003/EX/001PDF p 2 §§3–7; subsequent safety and patient informationExact formulation, process, source shelf life and formulation-specific precautions; independent factual compilation, not official translation.2026-10-14
- USP — General Chapter <795> Frequently Asked QuestionsNovember 1, 2023 FAQ; rechecked 14 October 2026Questions 52, 54–56, 61, 64–66General category/extension rules only; not exact-product stability evidence.2026-10-14